-
Mashup Score: 44
Stay informed with latest cancer breakthroughs, treatments, updates from leading hematology oncology experts. Insights from top cancer conferences and podcasts.
Source: oncbrothers.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 35Is it Time to Forget the 5-Fluorouracil Bolus? - 2 month(s) ago
“Is it Time to Forget the 5-Fluorouracil Bolus?” published on Oct 2024 by National Comprehensive Cancer Network.
Source: jnccn.orgCategories: General Medicine News, Partners & KOLsTweet-
RT @dr_yakupergun: Is it Time to Forget the 5-Fluorouracil Bolus? @JNCCN https://t.co/ZJ60TzcqWF https://t.co/8Avon2kdON
-
-
Mashup Score: 18
Stay informed with latest cancer breakthroughs, treatments, updates from leading hematology oncology experts. Insights from top cancer conferences and podcasts.
Source: oncbrothers.comCategories: General Medicine News, Partners & KOLsTweet-
#GynOnc: with @ShannonWestin we discuss the current treatment landscape/algorithm for #EndometrialCancer Full discussion: - https://t.co/E9hxiQO1Ce - https://t.co/0I27ia9bKg - Also on the “Oncology Brothers” podcast #gyncsm #MedTwitter #OncTwitter @CancerNetwrk #MedX https://t.co/bK3uKDUXv5
-
-
Mashup Score: 56DeLLphi-301 - FDA Approval of Tarlatamab in Patients with Previously Treated Small Cell Lung Cancer (SCLC) - 2 month(s) ago
Stay informed with latest cancer breakthroughs, treatments, updates from leading hematology oncology experts. Insights from top cancer conferences and podcasts.
Source: oncbrothers.comCategories: General Medicine News, Partners & KOLsTweet-
#LungCancer: Here we 🗣️ the @US_FDA approval of #Tarlatamab (first BiTE in Solid malignancies) for #SmallCellLungCancer w/ @drshieldsmd Full Discussion: - https://t.co/3sBxyhysU2 - Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter @SclcSMASHERS #sclc #lcsm https://t.co/kYU0hRYEV1
-
-
Mashup Score: 34Non–Small Cell Lung Cancer (NSCLC) with Actionable Mutations - 2 month(s) ago
Balazs Halmos, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss the treatment algorithm for patients with non–small cell lung cancer with actionable mutations.
Source: www.cancernetwork.comCategories: General Medicine News, Partners & KOLsTweet-
#LungSeries: w/ @DrSteveMartin we 🗣️ the SoC for mNSCLC w/🎯mutation in 1L (Osi, Ami, Alectinib, Lorlatinib, et al) Full discussion: - https://t.co/5bMCMgA4P4 - https://t.co/AKwjTkgN49 - Also on the “Oncology Brothers” podcast @CancerNetwrk #lcsm #OncTwitter #MedTwitter https://t.co/SCE6Nn5sXK
-
-
Mashup Score: 33
Stay informed with latest cancer breakthroughs, treatments, updates from leading hematology oncology experts. Insights from top cancer conferences and podcasts.
Source: oncbrothers.comCategories: General Medicine News, Partners & KOLsTweet-
#LungCancer: we🗣️the @US_FDA approval of #Durvalumab (+ options in periOp/PostOp) for resectable NSCLC w/ @maraantonoff & @PatelOncology Full Discussion: - https://t.co/p16bUJj3Us - https://t.co/wDr1Joi03B - Also on “Oncology Brothers” podcast #OncTwitter #lcsm @TargetedOnc https://t.co/QJCESM7wGS
-
-
Mashup Score: 46Oncology Brothers' Event Registration - 2 month(s) ago
Thank you for your interest in attending the Oncology Brothers’ live event, “Advancements in Oncology: Today’s Data for Tomorrow’s Practice,” hosted by Drs. Rahul and Rohit Gosain, coinciding with ASH 2024. Event Details: Date & Time: Sunday, December 8, 2024 | 6:30-8:30 PM PST Time: 6:30-8:30 PM (6:30 PM: Cocktails & Networking; 7-8:30 PM: Panel Discussions) Location: Skybox Penthouse at DiamondView Tower | 350 Tenth Ave, 15th Fl, San Diego, CA For questions, changes, or other inquiries please contact Kerrie Keegan: Kerrie@SignifyMD.com
Source: docs.google.comCategories: General Medicine News, Partners & KOLsTweet-
Going to #ASH24? See you there to discuss the current SoC & how the data from #ASH24 will change our practice! InPerson: Dec 8, 2024 w/ @CarrawayHetty @Dr_AmerZeidan @VincentRK @DrAEvens @Ccostello7 @DrLaCasce Register https://t.co/sU9IJYuxz7 #AdvInOnc24 #HemeTwitter https://t.co/PtFdUOcNeK
-
-
Mashup Score: 34Is it Time to Forget the 5-Fluorouracil Bolus? - 2 month(s) ago
“Is it Time to Forget the 5-Fluorouracil Bolus?” published on Oct 2024 by National Comprehensive Cancer Network.
Source: jnccn.orgCategories: General Medicine News, Partners & KOLsTweet-
RT @dr_yakupergun: Is it Time to Forget the 5-Fluorouracil Bolus? @JNCCN https://t.co/ZJ60TzcqWF https://t.co/8Avon2kdON
-
-
Mashup Score: 34Is it Time to Forget the 5-Fluorouracil Bolus? - 2 month(s) ago
“Is it Time to Forget the 5-Fluorouracil Bolus?” published on Oct 2024 by National Comprehensive Cancer Network.
Source: jnccn.orgCategories: General Medicine News, Partners & KOLsTweet-
RT @dr_yakupergun: Is it Time to Forget the 5-Fluorouracil Bolus? @JNCCN https://t.co/ZJ60TzcqWF https://t.co/8Avon2kdON
-
-
Mashup Score: 56Lung Cancer ESMO 2024 Highlights: Key Studies Discussed LAURA, MARIPOSA, MARIPOSA-2, ADRIATIC - 2 month(s) ago
Stay informed with latest cancer breakthroughs, treatments, updates from leading hematology oncology experts. Insights from top cancer conferences and podcasts.
Source: oncbrothers.comCategories: General Medicine News, Partners & KOLsTweet-
#LungCancer Highlights #ESMO24 w/ @StephenVLiu Updates on: ⭐️ #LAURA ⭐️ #MARIPOSA ⭐️ #MARIPOSA2 ⭐️ #ADRIATIC Full🗣️: - https://t.co/eaTRutMIqe - https://t.co/BGnMMEUBVM - Also on the “Oncology Brothers” podcast #lcsm #OncTwitter #MedTwitter @TargetedOnc @myESMO #MedEd https://t.co/20y5ResmwB
-
#GynOnc: with @DrMMurphy we covered the current treatment landscape/algorithm for #OvarianCancer Full discussion: - https://t.co/ZNR4upjzkB - https://t.co/RAF1ygwDKz - Also on the “Oncology Brothers” podcast #gyncsm #MedTwitter #OncTwitter @CancerNetwrk #MedX https://t.co/Yo43wrDXyh